Related Experiment Video
Updated: Jul 17, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients
Holger Thiele1, Peter Sick, Enno Boudriot
1Department of Internal Medicine/Cardiology, University of Leipzig-Heart Centre, Strümpellstr. 39, 04289 Leipzig, Germany. thielh@medizin.uni-leipzig.de
European Heart Journal
|March 1, 2005
Summary
Left ventricular assist device (VAD) support improved hemodynamic function in patients with cardiogenic shock after myocardial infarction more effectively than intra-aortic balloon pump (IABP). However, VAD use was associated with increased complications, with similar 30-day mortality rates.
Area of Science:
- Cardiology
- Mechanical Circulatory Support
- Acute Myocardial Infarction
Background:
- Mortality in cardiogenic shock (CS) post-acute myocardial infarction (AMI) remains high despite current treatments.
- Percutaneous coronary intervention (PCI) and intra-aortic balloon pump (IABP) are standard therapies, but their efficacy is limited.
Purpose of the Study:
- To evaluate the efficacy and safety of a percutaneous left ventricular assist device (VAD) compared to IABP in patients with CS following AMI.
- To assess the impact of VAD support on hemodynamic parameters and mortality.
Main Methods:
- A randomized trial comparing percutaneous VAD support (n=21) versus IABP (n=20) in patients with CS after AMI undergoing PCI.
- Primary outcome was cardiac power index; secondary outcomes included other hemodynamic and metabolic variables, complications, and 30-day mortality.
Main Results:
- VAD support significantly improved cardiac power index (0.22 to 0.37 W/m2) compared to IABP (0.22 to 0.28 W/m2).
- VAD support showed more effective improvement in hemodynamic and metabolic parameters.
- However, VAD use led to significantly higher rates of severe bleeding and limb ischemia.
Conclusions:
- Percutaneous VAD support offers superior hemodynamic improvement in CS post-AMI compared to IABP.
- Despite enhanced hemodynamic effects, VAD therapy is associated with increased procedural complications.
- 30-day mortality rates were similar between the VAD and IABP groups.
